Thu, Feb 20, 2020
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Prophecy Asset Management Allocates to Birch Island Capital's launch

Friday, October 27, 2017
Opalesque Industry Update - Prophecy Asset Management, LP, a New York-based allocator and seed capital source for equity long/short hedge fund managers, has allocated $30 million to a portfolio created by Birch Island Capital, a private investment firm in Cambridge, MA founded by a team of current Massachusetts Institute of Technology ("MIT") students majoring in Economics, Finance and Computer Science. Birch Island's innovative equity investing strategy incorporates advanced methods of statistical machine learning combined with fundamental analysis applied to a scalable quantitative portfolio construction process.

"While scouting for innovative investment strategies, different trading methodologies and new launches, we were introduced by our Boston brokerage partner Weeden & Co. to the Birch Island team, leading to an initial in-person April meeting and a July allocation of $30 million," noted Jeffrey Spotts, CEO & Founder of Prophecy. "As an allocator actively seeking opportunities to deploy a steady flow of investor capital, we interview over 1000 managers a year from a wide range of firms, long-only as well as long/short strategies, start-ups, emerging and established managers."

"We assembled our investment team of MIT classmates early in the 2016-2017 school year, each of us focused on a distinct aspect of collaboration toward launching our highly quantitative investment strategy, while realizing the need to build an infrastructure supporting the business formation and strategy launch objectives," commented John Reece, Birch Island's Managing Partner & MIT Economics/Finance major. "Our backgrounds and interests prior to MIT and Birch Island include: trading and investing from age 15; computer science/economics double major interested in investments and business development. We have since added an advising mentor with over 25 years of professional experience in valuation."

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. PE/VC: Venture debt: Is it a loan? Is it equity? Is it an pportunity?, PE, VC investments in India hit all-time high in 2019[more]

    Venture debt: Is it a loan? Is it equity? Is it an pportunity? From Forbes: Venture Capital is usually the default option for fast-growth startups looking for a cash injection, thanks to our willingness to take risks in return for equity, and with no need to pay anything back - at least

  2. Other Voices: Evolution of shrinking hedge fund fees - what do investors and managers need to know?[more]

    By Don Steinbrugge, Founder and CEO, Agecroft Partners (DonSteinbrugge@agecroftpartners.com): Hedge funds fees remain under extreme pressure across the industry. This strong trend is driven by declining return expectations from investors, inc

  3. COVID-19: Investors track ships, chase rumours to get edge on COVID-19 risks, Coronavirus risk puts the bull run on pause, China was wise to let markets stumble[more]

    Investors track ships, chase rumours to get edge on COVID-19 risks From Reuters: As investors crunch numbers to determine how the coronavirus will hit China's economy, hedge fund manager Nathaniel Polachek has tied much of his outlook to the fate of a ship anchored near Weihai, China.

  4. Bruce Berkowitz is back!, Coatue's new quant fund lost money in the fourth quarter[more]

    Bruce Berkowitz is back! From Institutional Investor: Famed value investor Bruce Berkowitz has hit hard times over the past decade, with big bets on losers like Eddie Lampert's Sears Holdings. In fact, over the past 10 years, his Fairholme Fund's annualized return is only 4.89 percent -

  5. Opalesque Exclusive: Optima A.M. bets on healthcare and biotech innovations with long/short strategy[more]

    B. G., Opalesque Geneva: Optima Asset Management has just launched the Optima Healthcare and Biotechnology strategy, which will be managed by five portfolio managers